What is the price target for NUVA stock?
22 analysts have analysed NUVA and the average price target is 50.72 USD. This implies a price increase of 27.6% is expected in the next year compared to the current price of 39.75.
NASDAQ:NUVA • US6707041058
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for NUVASIVE INC (NUVA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2023-08-04 | Barclays | Maintains | Overweight -> Overweight |
| 2023-08-04 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-07-19 | Truist Securities | Maintains | Hold -> Hold |
| 2023-05-31 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-05-15 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-05-12 | Barclays | Maintains | Overweight -> Overweight |
| 2023-05-11 | RBC Capital | Reiterate | Outperform -> Outperform |
| 2023-05-11 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2023-02-23 | JP Morgan | Maintains | Neutral |
| 2023-02-23 | Morgan Stanley | Maintains | Equal-Weight |
| 2023-02-10 | Wells Fargo | Downgrade | Overweight -> Equal-Weight |
| 2023-02-10 | Truist Securities | Downgrade | Buy -> Hold |
| 2023-02-10 | Citigroup | Downgrade | Buy -> Neutral |
| 2023-02-09 | Piper Sandler | Downgrade | Overweight -> Neutral |
| 2023-01-31 | Truist Securities | Maintains | Buy |
| 2023-01-06 | Needham | Downgrade | Buy -> Hold |
| 2022-11-10 | Needham | Maintains | Buy |
| 2022-11-10 | RBC Capital | Maintains | Outperform |
| 2022-11-10 | Wells Fargo | Maintains | Overweight |
| 2022-11-10 | Morgan Stanley | Maintains | Equal-Weight |
| 2022-11-10 | Piper Sandler | Maintains | Overweight |
| 2022-10-18 | Barclays | Initiate | Overweight |
| 2022-10-12 | Jefferies | Initiate | Hold |
| 2022-10-07 | Truist Securities | Maintains | Buy |
| 2022-10-07 | Baird | Maintains | Neutral |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.051B -10.06% | 1.139B 8.41% | 1.202B 5.53% | 1.306B 8.66% | 1.39B 6.43% | 1.486B 6.91% | 1.568B 5.52% | 1.719B 9.63% | |
| EBITDA YoY % growth | 191.1M -25.56% | 206.214M 7.91% | 230.473M 11.76% | 309.08M 34.11% | 342.72M 10.88% | 375.41M 9.54% | 430.9M 14.78% | 496.74M 15.28% | |
| EBIT YoY % growth | 50.2M -58.55% | 56.69M 12.93% | 83.44M 47.19% | 171.49M 105.52% | 198.43M 15.71% | 228.85M 15.33% | 272.85M 19.23% | 299.88M 9.91% | |
| Operating Margin | 4.78% | 4.98% | 6.94% | 13.13% | 14.28% | 15.40% | 17.40% | 17.45% | |
| EPS YoY % growth | 1.22 -50.81% | 1.69 38.52% | 1.98 17.16% | 2.26 13.97% | 2.61 15.67% | 3.00 15.06% | 3.30 10.04% | 3.87 16.98% |
All data in USD
| Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.56 3.73% | 0.64 49.43% | 0.55 16.91% | 0.63 11.68% | 0.63 12.54% | 0.72 12.28% |
| Revenue Q2Q % growth | 322.42M 9.19% | 345.01M 12.95% | 331.86M 7.85% | 345.16M 8.61% | 342.77M 6.31% | 361.49M 4.78% |
| EBITDA Q2Q % growth | 79.562M -40.97% | 85.248M -48.48% | 77.171M 70.55% | 86.883M -7.73% | 87.733M 10.27% | 94.865M 11.28% |
| EBIT Q2Q % growth | 43.773M 78.08% | 50.241M 172.77% | 41.419M 251.60% | 47.173M 69.83% | 48.32M 10.39% | 57.64M 14.73% |
All data in USD
22 analysts have analysed NUVA and the average price target is 50.72 USD. This implies a price increase of 27.6% is expected in the next year compared to the current price of 39.75.
NUVASIVE INC (NUVA) will report earnings on 2023-11-07, after the market close.
The consensus EPS estimate for the next earnings of NUVASIVE INC (NUVA) is 0.56 USD and the consensus revenue estimate is 322.42M USD.
The number of analysts covering NUVASIVE INC (NUVA) is 22.